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Multidrug-resistant organisms are a growing problem 
in every facet of medicine globally. With the need to 
address this ever-increasing threat comes a need for 
new drugs and new interventions. Infections caused 
by multidrug-resistant organisms have resulted in 
high mortality and morbidity all over the world. This is because 
there are few, if any, pharmaceutical and antimicrobial options to 
treat them. The pipeline is running dry, and a ‘nil-antibiotic’ era is 
approaching. It’s a scary thought – no effective antimicrobial agent 
available anywhere in the world.
We need to conserve what we have, and the answer lies in 
antimicrobial stewardship. If put into practice, this will assist in 
curbing the problem of multidrug-resistant organisms. The fight 
against these pathogens and the struggle to conserve antimicrobials 
have many facets, but surveillance remains the key.
Antimicrobial stewardship is a team approach and involves many 
aspects of healthcare, working towards a common goal.
A recent study in the trauma intensive care unit (ICU) at Inkosi 
Albert Luthuli Central Hospital in Durban, South Africa, highlights 
the key role that surveillance alone plays in curbing overuse of 
antimicrobials and reducing multidrug resistance.[1] Surveillance 
was key to establishing the flora typical of the unit and to choosing 
empiric therapy, with the help of an antibiogram based on the 
findings of the surveillance. Patients admitted to the unit were started 
on empiric therapy when they presented with sepsis. In more than 
90% of cases, empiric therapy proved appropriate. Importantly, there 
was no need to use initial ultrabroad-spectrum therapy regimens in 
the form of a carbapenem, a glycopeptide and an antifungal.
Most ICUs around the world employ a de-escalation strategy 
whereby ultrabroad-spectrum therapy is used and then tailored down 
or de-escalated once microbiological cultures become available. The 
Durban study highlights the fact that surveillance and knowledge of 
local flora plus antimicrobial susceptibility patterns make it possible 
to use more tailored, narrow-spectrum antimicrobials. Because there 
is no overuse of broad-spectrum antimicrobials, the emergence of 
multidrug-resistant pathogens is curbed.
Antimicrobial stewardship is a key component of the multifaceted 
approach to preventing antimicrobial resistance. Good antimicrobial 
stewardship involves selecting an appropriate drug and optimising its 
dose and duration to cure an infection, while minimising toxicity and 
the conditions that might select for resistant bacterial strains. With 
such an active surveillance programme and empiric antimicrobial 
policy, blanket cover is rarely indicated. The empiric choice of 
antimicrobials should cover the most likely pathogens, endemic to 
the specific location. It is important to note that this does not refer 
to all pathogens, and prescriptions cannot be based on uncommon 
organisms unless the situation dictates the need.
There are many challenges to successful stewardship, but its aims 
are education, prevention of antimicrobial overuse, and minimising 
the development of resistance. Pivotal to success are interested 
clinicians and microbiologists, knowledge of local resistance patterns, 
and an antimicrobial policy that optimises the choice, dose and 
duration of therapy.
Almost 70 years ago Sir Alexander Fleming correctly predicted 
the development of antimicrobials when he stated, ‘The intensive 
research which penicillin has stimulated may bring forth others as 
good, or even better, or the chemists may be able to modify the 
penicillin molecule so that its power is increased or its limitations 
are removed. There is still plenty of scope for further advance.’[2] 
In the same book (edited by Fleming), however, Porritt and 
Mitchell made the pessimistic prophecy, ‘As with sulphonamides, 
the prophylactic use of penicillin will carry the risk of breeding 
resistant strains, a matter of serious practical importance that 
cannot be dismissed lightly.’[3] 
Unfortunately the indiscriminate use of drugs foreseen by 
Fleming has promoted the emergence of resistance to even the 
broadest-spectrum antimicrobials. While his prediction that there 
is scope for further advance in the discovery of new antimicrobials 
undoubtedly held true in the first half of the 20th century, the 
same cannot be said today. There are few new avenues, if any, and 
strict measures must be implemented to enforce infection control 
and curb indiscriminate and inappropriate prescribing.
When combined with regular bacterial surveillance, antimicrobial 
stewardship allows accurate empiric antimicrobial prescriptions 
with minimal need for de-escalation. This policy may reduce the 
emergence of multidrug-resistant pathogens, avoiding the need 
for broad-spectrum antimicrobials and the attendant problems of 
overuse. 
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